Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 2 TO FORM S-1 - ZS Pharma, Inc. | d698362ds1a.htm |
| EX-5.1 - EX-5.1 - ZS Pharma, Inc. | d698362dex51.htm |
| EX-23.1 - EX-23.1 - ZS Pharma, Inc. | d698362dex231.htm |
Exhibit 99.2
Consent of Director Nominee
ZS Pharma, Inc.
508 Wrangler Drive
Suite 100
Coppell, Texas 75019
Pursuant to Rule 438 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the Registration Statement on Form S-1 (the “Registration Statement”) of ZS Pharma, Inc. (the “Company”), the undersigned hereby consents to being named and described as a person that is to become a director of the Company in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, and any amendment to such Registration Statement, and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.
[remainder of page intentionally left blank]
1
IN WITNESS WHEREOF, the undersigned has executed this consent as of June 3, 2014.
| /s/ Srinivas Akkaraju Srinivas Akkaraju | ||
2